SecBot SecBot
6-K ·Filed May 8, 2026

DRTSW

Alpha Tau Medical Ltd.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago SEC0001213900-26-053597
Notable filing: 6-K
Actionable Insight • Neutral

Monitor the May 11 conference call for any safety or efficacy signals from the first three GBM patients. Positive interim data could provide a near-term catalyst, but given the tiny sample size and early stage, any price move is likely speculative and short-lived.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$1.02
T+0 close · May 8, 2026 · via day close
Latest settled
+223.53%
T+60 · $3.30
Vs SPY
+218.69%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 8 $1.02entry
  2. T+1 · 6mo ago 0.00%α −0.23% · $1.02
  3. T+5 · 6mo ago 0.00%α −1.46% · $1.02
  4. T+20 · 5mo ago 0.00%α −0.02% · $1.02
  5. T+60 · 3mo ago +223.53%α +218.69% · $3.30
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Alpha Tau Medical Ltd. filed a 6-K on May 8, 2026, announcing a conference call to discuss interim clinical data from the first three patients treated in its REGAIN trial for recurrent glioblastoma. The filing is a routine update on early-stage clinical progress with no financial data or material corporate events disclosed.

Key Facts

  • Conference call scheduled for May 11, 2026 at 8:30am ET to discuss interim data from first three patients in REGAIN trial.
  • REGAIN trial is a U.S. study for recurrent glioblastoma not amenable to surgical resection, expected to enroll up to ten patients.
  • No financial results, guidance, or material agreements were disclosed in the filing.

Financial Impact

No financial figures reported; pre-revenue clinical-stage company.

Risk Factors

  • Interim data from only three patients is not statistically meaningful and may not predict final trial results.
  • Alpha Tau has no approved products and relies on future funding; the 20-F notes significant losses and need for additional capital.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-053597
Document: ea028978302ex99-1.htm0001213900-26-053597
Document: 0001213900-26-053597-index-headers.html0001213900-26-053597
Document: 0001213900-26-053597-index.html0001213900-26-053597
Document: 0001213900-26-053597.txt0001213900-26-053597

Track record

14 reports on DRTSW

Performance horizon

9 of 9 bullish or bearish reports moved the stock their way by T+60. Best: +292.16% at T+60 after the Jun 3, 2026 report. 9 of 9 went positive at some point.

Filters
  1. Jun 3, 202623w ago 6-K Bullish 7/10 Entry $1.02 to $4.00 ▲ +292.16% +289.66% vs SPY
  2. Jun 1, 202624w ago 6-K Bullish 7/10 Entry $1.02 to $3.89 ▲ +281.37% +280.14% vs SPY
  3. May 18, 202626w ago 6-K Neutral 5/10 Entry $1.02 to $3.89 ▲ +281.37% +275.08% vs SPY
  4. May 11, 202627w ago 6-K Bullish 7/10 Entry $1.02 to $3.37 ▲ +230.39% +226.00% vs SPY
  5. May 11, 202627w ago 6-K Bullish 6/10 Entry $1.02 to $3.37 ▲ +230.39% +226.00% vs SPY
  6. May 8, 202627w ago 6-K Neutral 3/10 Viewing Entry $1.02 to $3.30 ▲ +223.53% +218.69% vs SPY
  7. May 8, 202627w ago 6-K Bullish 6/10 Entry $1.02 to $3.30 ▲ +223.53% +218.69% vs SPY
  8. May 7, 202627w ago 6-K Neutral 3/10 Entry $1.02 to $2.58 ▲ +152.94% +149.11% vs SPY
  9. May 5, 202627w ago 6-K Neutral 3/10 Entry $1.02 to $2.70 ▲ +164.71% +161.97% vs SPY
  10. May 4, 202628w ago 6-K Bullish 7/10 Entry $1.02 to $2.29 ▲ +124.51% +122.65% vs SPY
Showing 10 of 14

US Market Status

Market Closed · Opens in 8h 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 8, 2026